Risk of contrast-induced nephropathy for patients receiving intravenous vs. intra-arterial iodixanol administration

Gregory E. Tong,Sant Kumar,Karen C. Chong,Nikita Shah,Margaret Wong,Jeffrey M. Zimmet,Zhen J. Wang,Judy Yee,Yanjun Fu,Benjamin M. Yeh

Risk of contrast-induced nephropathy for patients receiving intravenous vs. intra-arterial iodixanol administration

2016

Gregory E. Tong
Sant Kumar
Karen C. Chong
Nikita Shah
Margaret Wong
Jeffrey M. Zimmet
Zhen J. Wang
Judy Yee
Yanjun Fu
Benjamin M. Yeh

Purpose To compare the incidence of contrast-induced nephropathy (CIN) for intravenous vs. intra-arterial administration of iodixanol, compared to non-administration.

Keywords:

Renal function
Creatinine
Urology
Radiology
Cardiac catheterization
Iodixanol
Contrast-induced nephropathy
Retrospective cohort study
Nephropathy
Diabetes mellitus
Medicine
Hepatology
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations